🇺🇸 FDA
Patent

US 10888589

Modulation of stem cells using zinc finger proteins

granted A61KA61K35/12A61K35/545

Quick answer

US patent 10888589 (Modulation of stem cells using zinc finger proteins) held by Sangamo Therapeutics, Inc. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/12, A61K35/545, A61P, A61P35/00